Skip to main content
NVDA+0.24%AAPL+0.03%GOOGL-0.61%MSFT+0.09%AMZN+0.08%TSM+0.96%SPCX+5.15%META+0.16%AVGO+0.07%TSLA+0.04%SKHY+0.02%BRK-B+0.59%LLY+0.18%MU+0.27%JPM-1.01%WMT-0.55%AMD+1.65%V-1.25%XOM-3.54%JNJ+0.03%ASMLa+1.26%INTC+4.03%0700.HK-1.23%MA-0.96%ABBV-0.17%1398.HK+0.67%CSCO-2.12%CVX-2.86%BAC-2.72%ORCL+2.00%COST-0.84%KO-0.95%DELL+3.64%CAT-0.10%0005.HK+0.81%PG+0.24%HSBA.L+0.27%UNH-0.18%LRCX-0.61%AP2d+0.95%AMAT-1.37%GE+1.91%MS-1.83%3988.HK+0.34%1816.HK-0.69%NFLX-1.91%0857.HK-1.90%HD-0.99%PM-1.24%0939.HK+0.31%USDJPY+1.72%NZDUSD-1.60%EURUSD-1.18%AUDUSD-1.15%USDCHF+1.12%GBPUSD-1.03%USDTHB+0.96%CADJPY+0.88%USDCAD+0.86%NZDCAD-0.82%CHFJPY+0.74%GBPJPY+0.66%GBPNZD+0.60%AUDJPY+0.57%AUDNZD+0.52%EURJPY+0.51%NZDCHF-0.50%EURNZD+0.47%GBPTRY+0.41%EURCAD-0.36%GBPHKD+0.32%USDTRY+0.30%AUDCAD-0.29%GBPMXN-0.28%CADCHF+0.26%GBPCAD-0.20%USDILS+0.16%NZDJPY+0.10%GBPAUD+0.10%EURGBP-0.08%GBPCHF+0.07%EURCHF-0.06%USDCNH+0.06%USDCOP-0.04%EURAUD-0.02%USDHKD+0.02%AUDCHF-0.02%PLNJPY0.00%EURPLN0.00%CHFNOK0.00%USDPLN0.00%USDMXN0.00%USDNOK0.00%NZDSGD0.00%USDZAR0.00%EURSEK0.00%GBPZAR0.00%USDSEK0.00%GBPSGD0.00%EURDKK0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%USDDKK0.00%EURCZK0.00%NOKJPY0.00%EURNOK0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDMXN0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.59%ETHUSD+0.34%USDTUSD0.00%XRPUSD+0.87%SOLUSD+1.55%TRXUSDT+1.00%ZECUSDT+18.66%DOGEUSD+0.69%XMRUSDT-3.11%LINKUSD+0.46%XLMUSD+3.07%BCHUSDT+0.73%UNIUSD+1.74%LTCUSD-0.03%TONUSD+29.54%HBARUSDT-1.31%SUIUSD+2.94%TAOUSDT+0.98%AAVEUSD-2.41%DOTUSDT+6.88%ICPUSDT+1.32%ONDOUSDT+3.56%WLDUSDT+2.11%ARBUSDT+9.06%ATOMUSDT-1.15%JUPUSDT+0.20%INJUSDT-0.91%STXUSDT+1.15%FETUSDT+2.64%PYTHUSDT-0.94%TIAUSDT+2.70%SEIUSDT+1.07%IMXUSDT-1.25%GRTUSDT+1.77%OPUSDT-0.14%WIFUSDT+1.40%POLUSDT+0.66%IOTAUSDT-0.20%AXSUSDT+0.09%FARTCOINUSDT-0.27%EOSUSDT-0.18%DYDXUSDT+0.24%ORDIUSDT+2.38%GALAUSDT-2.15%NOTUSDT+1.37%RONINUSDT-2.40%NVDA+0.24%AAPL+0.03%GOOGL-0.61%MSFT+0.09%AMZN+0.08%TSM+0.96%SPCX+5.15%META+0.16%AVGO+0.07%TSLA+0.04%SKHY+0.02%BRK-B+0.59%LLY+0.18%MU+0.27%JPM-1.01%WMT-0.55%AMD+1.65%V-1.25%XOM-3.54%JNJ+0.03%ASMLa+1.26%INTC+4.03%0700.HK-1.23%MA-0.96%ABBV-0.17%1398.HK+0.67%CSCO-2.12%CVX-2.86%BAC-2.72%ORCL+2.00%COST-0.84%KO-0.95%DELL+3.64%CAT-0.10%0005.HK+0.81%PG+0.24%HSBA.L+0.27%UNH-0.18%LRCX-0.61%AP2d+0.95%AMAT-1.37%GE+1.91%MS-1.83%3988.HK+0.34%1816.HK-0.69%NFLX-1.91%0857.HK-1.90%HD-0.99%PM-1.24%0939.HK+0.31%USDJPY+1.72%NZDUSD-1.60%EURUSD-1.18%AUDUSD-1.15%USDCHF+1.12%GBPUSD-1.03%USDTHB+0.96%CADJPY+0.88%USDCAD+0.86%NZDCAD-0.82%CHFJPY+0.74%GBPJPY+0.66%GBPNZD+0.60%AUDJPY+0.57%AUDNZD+0.52%EURJPY+0.51%NZDCHF-0.50%EURNZD+0.47%GBPTRY+0.41%EURCAD-0.36%GBPHKD+0.32%USDTRY+0.30%AUDCAD-0.29%GBPMXN-0.28%CADCHF+0.26%GBPCAD-0.20%USDILS+0.16%NZDJPY+0.10%GBPAUD+0.10%EURGBP-0.08%GBPCHF+0.07%EURCHF-0.06%USDCNH+0.06%USDCOP-0.04%EURAUD-0.02%USDHKD+0.02%AUDCHF-0.02%PLNJPY0.00%EURPLN0.00%CHFNOK0.00%USDPLN0.00%USDMXN0.00%USDNOK0.00%NZDSGD0.00%USDZAR0.00%EURSEK0.00%GBPZAR0.00%USDSEK0.00%GBPSGD0.00%EURDKK0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%USDDKK0.00%EURCZK0.00%NOKJPY0.00%EURNOK0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDMXN0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.59%ETHUSD+0.34%USDTUSD0.00%XRPUSD+0.87%SOLUSD+1.55%TRXUSDT+1.00%ZECUSDT+18.66%DOGEUSD+0.69%XMRUSDT-3.11%LINKUSD+0.46%XLMUSD+3.07%BCHUSDT+0.73%UNIUSD+1.74%LTCUSD-0.03%TONUSD+29.54%HBARUSDT-1.31%SUIUSD+2.94%TAOUSDT+0.98%AAVEUSD-2.41%DOTUSDT+6.88%ICPUSDT+1.32%ONDOUSDT+3.56%WLDUSDT+2.11%ARBUSDT+9.06%ATOMUSDT-1.15%JUPUSDT+0.20%INJUSDT-0.91%STXUSDT+1.15%FETUSDT+2.64%PYTHUSDT-0.94%TIAUSDT+2.70%SEIUSDT+1.07%IMXUSDT-1.25%GRTUSDT+1.77%OPUSDT-0.14%WIFUSDT+1.40%POLUSDT+0.66%IOTAUSDT-0.20%AXSUSDT+0.09%FARTCOINUSDT-0.27%EOSUSDT-0.18%DYDXUSDT+0.24%ORDIUSDT+2.38%GALAUSDT-2.15%NOTUSDT+1.37%RONINUSDT-2.40%
IT

Intellia Therapeutics, Inc. (NTLA)

NASDAQ • Healthcare

$11.49
+$0.13 (+1.1%)
Market closed

Last close at September 16, 2026 at 20:00 UTC

Open$11.46
Day Range$11.37 - $11.76
Avg. Volume (3M)3.5M
Market Cap$1.6B
52 Week Range
$7.95$28.25
Next EarningsIn 50 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$7.6M100%
Gross Profitminus cost of goods$7.6M100%

Fundamentals & Financials

Revenue (TTM)
$59.5M
Net Income (TTM)
-$399.9M
EPS (TTM)
-$3.36
ROA (TTM)
-46.66%
Current Ratio
6.65

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+16.2%Q1 2026-$0.83
+12.0%Q2 2026-$0.81
-0.1%Q3 2026-$0.8
Next

Nov 5

in 50 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. is a NASDAQ-listed Biotechnology company developing genomic medicines through genome editing, with both in vivo and ex vivo programs. In FY2025, the company recorded $67.7 million in revenue. Intellia operates in the healthcare sector and centers its platform on CRISPR/Cas9-based therapeutic development.

Name
Intellia Therapeutics, Inc.
CEO
John Leonard
Website
www.intelliatx.com
Industry
Healthcare
Year Founded
2014
Employees
377

Today's Snapshot

AI-generated

NTLA closed 1.1% higher at 11.49, while its sector was flat.

Trading Volume

Above 10d avg 3.6M

4.5M

vs S&P 500 Today

Outperforming Market

+1.72%

Updated: September 16, 2026 at 20:27 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
NTLA displays a bearish bias characterized by weak momentum and broad moving-average pressure. Momentum measures such as CCI and MACD are negative and RSI sits below neutral, indicating bearish internals, while the stock trades beneath most short- and medium-term averages as well as below longer-term measures, which signals overall moving-average resistance. Trend strength is muted to modest and ATR shows moderate volatility, yet volume flow is negative on balance, reinforcing selling. The pivot is roughly at current levels and does not offset the downside signals. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$12.00 - $13.14
    Sell
  • RSI (14)39.67
    Neutral
  • Stochastic %K (14, 3, 3)9.04
    Buy
  • MACD Level (12, 26)-0.20
    Sell

Peers & Related Assets

SYRESpyre Therapeutics, Inc.
$91.17+0.2%
IMNMImmunome, Inc.
$23.46-2.0%
BCRXBioCryst Pharmaceuticals, Inc.
$8.43+3.3%
ZBIOZenas BioPharma, Inc.
$32.32+1.2%
ZYMEZymeworks Inc.
$26.24+0.7%
STOKStoke Therapeutics, Inc.
$27.91-0.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.